Bharat Biotech submits Phase III trial data for Covaxin
Bharat Biotech has submitted Phase III trial data for the Covaxin coronavirus vaccine to the DCGI (Drug Controller General of India). The drug regulator’s SEC (subject expert committee) is expected to meet around noon to discuss the results. The data has not yet been fully published in a recognised, peer-reviewed journal. Hyderabad-based Bharat Biotech is also expected to hold a… Continue reading "Bharat Biotech submits Phase III trial data for Covaxin"